Rolf Valter Rikard Kiessling

Title: Rolf Valter Rikard Kiessling: Innovator in Cancer Immunotherapy

Introduction

Rolf Valter Rikard Kiessling is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of immunotherapy, particularly in the treatment of cancer. His innovative approach has led to the development of a unique immunogenic composition aimed at enhancing cancer treatment.

Latest Patents

Rikard Kiessling holds a patent for an immunogenic composition for the treatment of cancer. This invention focuses on a composition that can be used in immunotherapy, specifically targeting cancer treatment. The patent describes an ex vivo method for obtaining a composition suitable for treating cancer in a subject. This method involves providing primary tumor cells derived from the subject and ex vivo contacting these tumor cells with a bromodomain and extra-terminal domain family member inhibitor, known as a BET inhibitor. He has 1 patent to his name.

Career Highlights

Rolf Valter Rikard Kiessling has established himself as a key figure in the field of cancer research. He is associated with Apgen Therapeutics AB, where he continues to work on innovative solutions for cancer treatment. His research has the potential to significantly impact the way cancer is treated, offering new hope to patients.

Collaborations

Rikard Kiessling collaborates with Jeroen Melief, a fellow researcher in the field. Their combined expertise enhances the development of effective cancer therapies.

Conclusion

Rolf Valter Rikard Kiessling is a pioneering inventor whose work in cancer immunotherapy is paving the way for new treatment options. His contributions are vital in the ongoing fight against cancer, and his innovative approaches continue to inspire advancements in medical research.